[
    {
        "text": "[ ♪ Intro ♪ ]",
        "start": 2.0,
        "duration": 8.769
    },
    {
        "text": "A lot of things about getting older can seem\nkinda fun -- like senior discounts, butterscotch",
        "start": 10.769,
        "duration": 4.761
    },
    {
        "text": "candies, and argyle sweaters.",
        "start": 15.53,
        "duration": 1.64
    },
    {
        "text": "But aging can come with plenty of problems,\ntoo.",
        "start": 17.17,
        "duration": 2.99
    },
    {
        "text": "And a big one is an increased risk of dementia.",
        "start": 20.16,
        "duration": 2.01
    },
    {
        "text": "You might hear people talk about Alzheimer’s\ndisease and other forms of dementia as natural",
        "start": 22.17,
        "duration": 4.08
    },
    {
        "text": "and unavoidable parts of getting older.",
        "start": 26.25,
        "duration": 1.79
    },
    {
        "text": "But even though we still don’t understand\neverything that happens in the brain with",
        "start": 28.04,
        "duration": 2.46
    },
    {
        "text": "these illnesses, there’s no reason they\nshould be impossible to prevent or cure.",
        "start": 30.5,
        "duration": 3.55
    },
    {
        "text": "And that’s why scientists are racing to\nunderstand how they work and develop treatments",
        "start": 34.05,
        "duration": 3.16
    },
    {
        "text": "and ways to prevent them, and there are new\nstudies coming out all the time.",
        "start": 37.21,
        "duration": 3.27
    },
    {
        "text": "But we still have a lot of work to do.",
        "start": 40.48,
        "duration": 1.43
    },
    {
        "text": "Even though they’re sometimes used interchangeably,\nAlzheimer’s disease and dementia are two",
        "start": 41.91,
        "duration": 3.55
    },
    {
        "text": "different things -- and neither is an inevitable\nresult of aging, even though age is the biggest",
        "start": 45.46,
        "duration": 4.45
    },
    {
        "text": "risk factor for both.",
        "start": 49.91,
        "duration": 1.54
    },
    {
        "text": "Dementia is a broad term for a group of symptoms,\nas opposed to one, specific disease.",
        "start": 51.45,
        "duration": 4.24
    },
    {
        "text": "People with dementia can have a wide variety\nof cognitive and memory issues, like problems",
        "start": 55.69,
        "duration": 4.17
    },
    {
        "text": "with language, comprehension, learning, and\nexecutive and social functioning.",
        "start": 59.86,
        "duration": 3.3
    },
    {
        "text": "It’s generally progressive, and often advances\nto the point where patients can’t live on their own.",
        "start": 63.16,
        "duration": 4.74
    },
    {
        "text": "And it can be caused by a lot of things.",
        "start": 67.95,
        "duration": 1.379
    },
    {
        "text": "One version is vascular dementia, where these\nsymptoms come from problems with blood flow",
        "start": 69.329,
        "duration": 3.751
    },
    {
        "text": "in the brain, like from a stroke, or from\nmuch smaller capillary blockages.",
        "start": 73.08,
        "duration": 3.82
    },
    {
        "text": "Another common kind is caused by buildups\nof a protein called alpha-synuclein in \npatients’ brains.",
        "start": 76.9,
        "duration": 5.1
    },
    {
        "text": "It’s known as Lewy body dementia, and can\noverlap with Parkinson’s disease.",
        "start": 82.09,
        "duration": 2.799
    },
    {
        "text": "There’s also frontotemporal dementia, where\nthe frontal and temporal lobes of the brain",
        "start": 84.889,
        "duration": 4.141
    },
    {
        "text": "start to degenerate.",
        "start": 89.03,
        "duration": 1.0
    },
    {
        "text": "It also seems to have more of a genetic component,\nalthough it’s been tough to pin down.",
        "start": 90.03,
        "duration": 3.769
    },
    {
        "text": "But most cases of dementia -- around 50 to\n80% of them -- are caused by Alzheimer’s",
        "start": 93.799,
        "duration": 4.46
    },
    {
        "text": "disease, which was first described over 100\nyears ago.",
        "start": 98.259,
        "duration": 2.65
    },
    {
        "text": "Like with dementia in general, Alzheimer’s\nsymptoms get worse over time.",
        "start": 100.909,
        "duration": 3.091
    },
    {
        "text": "They start with things like mild forgetfulness\nand difficulty concentrating, which a close",
        "start": 104.0,
        "duration": 3.429
    },
    {
        "text": "friend or family member might not even notice\nat first.",
        "start": 107.429,
        "duration": 2.37
    },
    {
        "text": "Then, the symptoms progress and include more\nintense forgetfulness, along with personality",
        "start": 109.799,
        "duration": 4.39
    },
    {
        "text": "and mood changes.",
        "start": 114.189,
        "duration": 1.02
    },
    {
        "text": "Eventually, the person can’t carry out most\ntasks, isn’t aware of their surroundings,",
        "start": 115.209,
        "duration": 4.02
    },
    {
        "text": "doesn’t recognize their family, and needs\nround-the-clock care.",
        "start": 119.229,
        "duration": 3.041
    },
    {
        "text": "Which is why scientists are working so hard\nto try and understand it.",
        "start": 122.27,
        "duration": 2.919
    },
    {
        "text": "After their symptoms become noticeable, patients\nlive an average of eight more years.",
        "start": 125.189,
        "duration": 3.641
    },
    {
        "text": "The cause of death varies, but often, as the\ndisease starts to affect more basic functions",
        "start": 128.83,
        "duration": 4.21
    },
    {
        "text": "like swallowing and heart rhythm, they become\nvulnerable to infections or heart attacks.",
        "start": 133.04,
        "duration": 3.97
    },
    {
        "text": "So far, scientists don’t know exactly what\ncauses Alzheimer’s, but they do know that",
        "start": 137.01,
        "duration": 3.6
    },
    {
        "text": "patients develop two major features in their\nbrains.",
        "start": 140.61,
        "duration": 2.7
    },
    {
        "text": "One is plaques, or deposits mostly made of\na protein called amyloid beta.",
        "start": 143.31,
        "duration": 3.66
    },
    {
        "text": "The other is tangles of another protein, called\ntau, that form inside of neurons.",
        "start": 146.97,
        "duration": 4.19
    },
    {
        "text": "Most people develop some plaques and tangles\nas they get older, but patients with Alzheimer’s",
        "start": 151.16,
        "duration": 3.82
    },
    {
        "text": "have a lot more of them, and they spread through\nthe brain as their illness gets worse.",
        "start": 154.98,
        "duration": 3.61
    },
    {
        "text": "So doctors think they must have something\nto do with the disease’s symptoms.",
        "start": 158.59,
        "duration": 3.69
    },
    {
        "text": "Our best idea right now is called the amyloid\nhypothesis, and it suggests that a buildup",
        "start": 162.28,
        "duration": 4.09
    },
    {
        "text": "of amyloid beta is mainly responsible for\nAlzheimer’s.",
        "start": 166.37,
        "duration": 3.33
    },
    {
        "text": "Scientists aren’t sure how, but the plaques\nmight disrupt communication between brain cells.",
        "start": 169.7,
        "duration": 4.2
    },
    {
        "text": "And besides clumping together to form plaques,\namyloid beta can also join together in bundles",
        "start": 173.98,
        "duration": 3.7
    },
    {
        "text": "that dissolve in the fluid in the brain.",
        "start": 177.68,
        "duration": 2.22
    },
    {
        "text": "When the immune system tries to clear those\nout, it can contribute to harmful inflammation.",
        "start": 179.9,
        "duration": 4.21
    },
    {
        "text": "But even if the amyloid hypothesis is right,\nthat protein isn’t the only thing causing problems.",
        "start": 184.11,
        "duration": 5.49
    },
    {
        "text": "There are also those tangles of tau protein,\nwhich seem to form after amyloid plaques,",
        "start": 189.65,
        "duration": 3.11
    },
    {
        "text": "and they lead to even more damage.",
        "start": 192.76,
        "duration": 1.7
    },
    {
        "text": "Normally, tau’s job is to stabilize microtubules,\nstructures neurons use as tiny highways to",
        "start": 194.46,
        "duration": 5.09
    },
    {
        "text": "shuttle nutrients and neurotransmitters inside\nthe cell.",
        "start": 199.55,
        "duration": 2.7
    },
    {
        "text": "But when tau abandons its responsibilities\nand forms tangles instead, it disrupts the",
        "start": 202.25,
        "duration": 4.27
    },
    {
        "text": "molecular highways.",
        "start": 206.52,
        "duration": 1.52
    },
    {
        "text": "So not only is there an 18-car pileup, but\nthe road itself has been washed out by a landslide.",
        "start": 208.04,
        "duration": 4.83
    },
    {
        "text": "As amyloid, inflammation, and tangles progress,\nthey disrupt all kinds of systems in the brain,",
        "start": 212.87,
        "duration": 4.64
    },
    {
        "text": "and a patient’s memory and cognition get\nprogressively worse.",
        "start": 217.51,
        "duration": 2.78
    },
    {
        "text": "And, unfortunately, there’s no way we know\nof to reverse all this.",
        "start": 220.29,
        "duration": 3.2
    },
    {
        "text": "We’re also not sure what causes someone\nto develop these plaques and tangles in the",
        "start": 223.49,
        "duration": 3.72
    },
    {
        "text": "first place.",
        "start": 227.21,
        "duration": 1.0
    },
    {
        "text": "Many researchers think Alzheimer’s disease\nis caused by interactions between a bunch",
        "start": 228.21,
        "duration": 3.16
    },
    {
        "text": "of factors, including genetics, overall health,\nand the environment.",
        "start": 231.37,
        "duration": 2.81
    },
    {
        "text": "Still, we do know of at least one case where\ngenetics alone definitely causes Alzheimer’s.",
        "start": 234.18,
        "duration": 4.81
    },
    {
        "text": "In about 1% of cases, the disease is caused\nby mutations in the amyloid-related genes",
        "start": 238.99,
        "duration": 4.95
    },
    {
        "text": "PSEN1 or PSEN2, or in APP, a protein that\ngets processed into amyloid beta.",
        "start": 243.94,
        "duration": 4.75
    },
    {
        "text": "If someone inherits just one copy of a mutated\ngene, they’ll develop Familial Alzheimer’s disease.",
        "start": 248.69,
        "duration": 5.31
    },
    {
        "text": "And these cases show up earlier in life -- in\nthe person’s 40s or 50s instead of their",
        "start": 254.07,
        "duration": 3.49
    },
    {
        "text": "60s or later.",
        "start": 257.56,
        "duration": 1.07
    },
    {
        "text": "Although we can’t cure either Alzheimer’s\nor dementia in general -- no matter what causes",
        "start": 258.63,
        "duration": 3.68
    },
    {
        "text": "it -- we at least have some treatment options\non the market right now that can slow its progression.",
        "start": 262.31,
        "duration": 4.79
    },
    {
        "text": "Today, there are two types of drugs used for\ntreating Alzheimer’s specifically: acetylcholinesterase",
        "start": 267.12,
        "duration": 4.06
    },
    {
        "text": "inhibitors and an NMDA antagonist.",
        "start": 271.18,
        "duration": 2.56
    },
    {
        "text": "The inhibitors increase levels of the neurotransmitter\nacetylcholine in the brain by blocking the",
        "start": 273.74,
        "duration": 4.459
    },
    {
        "text": "enzyme that normally breaks it down, which\ncan ease the cognitive symptoms of Alzheimer’s.",
        "start": 278.199,
        "duration": 5.231
    },
    {
        "text": "Researchers think the enzyme might also help\nform plaques and tangles, so blocking it might",
        "start": 283.43,
        "duration": 3.739
    },
    {
        "text": "slow that process down, too.",
        "start": 287.169,
        "duration": 1.581
    },
    {
        "text": "And the antagonist decreases the activity\nof the neurotransmitter glutamate, which tends",
        "start": 288.75,
        "duration": 4.279
    },
    {
        "text": "to excite the brain.",
        "start": 293.029,
        "duration": 1.081
    },
    {
        "text": "Lowering glutamate levels stops over-excited\nnerves from firing as often, which also seems",
        "start": 294.11,
        "duration": 4.339
    },
    {
        "text": "to ease symptoms.",
        "start": 298.449,
        "duration": 1.0
    },
    {
        "text": "Now, these drugs might slow the progression\nof Alzheimer’s, but they don’t stop or",
        "start": 299.449,
        "duration": 3.4
    },
    {
        "text": "reverse it -- we don’t know how to do that\nyet.",
        "start": 302.849,
        "duration": 2.491
    },
    {
        "text": "And, unfortunately, we also don’t have specific\nmedicines for dementias not caused by Alzheimer’s,",
        "start": 305.34,
        "duration": 4.75
    },
    {
        "text": "like vascular dementia.",
        "start": 310.09,
        "duration": 1.06
    },
    {
        "text": "Those patients can take medicine for Alzheimer’s,\nbut they don’t seem to work as well, and",
        "start": 311.15,
        "duration": 3.489
    },
    {
        "text": "doctors are looking for other options.",
        "start": 314.639,
        "duration": 1.86
    },
    {
        "text": "So far, there are some clinical trials to\ndevelop new drugs or test existing ones for",
        "start": 316.499,
        "duration": 3.861
    },
    {
        "text": "non-Alzheimer’s dementia, and those focus\non their specific characteristics -- like",
        "start": 320.36,
        "duration": 4.059
    },
    {
        "text": "treating blood flow in the brain for vascular\ndementia.",
        "start": 324.419,
        "duration": 2.31
    },
    {
        "text": "At least one of these appeared to slow cognitive\ndecline in more patients compared to a placebo,",
        "start": 326.729,
        "duration": 4.951
    },
    {
        "text": "but results overall have been mixed.",
        "start": 331.68,
        "duration": 1.87
    },
    {
        "text": "Most research today focuses on developing\nnew drugs for Alzheimer’s disease -- and",
        "start": 333.55,
        "duration": 3.94
    },
    {
        "text": "then getting them approved to treat other\ndementias, too.",
        "start": 337.49,
        "duration": 2.449
    },
    {
        "text": "Many of the drugs in the Alzheimer’s pipeline\nfocus on amyloid beta.",
        "start": 339.939,
        "duration": 3.35
    },
    {
        "text": "One of the hottest tools in drug development\nright now is antibodies, those Y-shaped molecules",
        "start": 343.289,
        "duration": 4.59
    },
    {
        "text": "your immune system makes to target foreign\nproteins.",
        "start": 347.879,
        "duration": 2.711
    },
    {
        "text": "Since a buildup of amyloid beta proteins is\na problem with Alzheimer’s, researchers",
        "start": 350.59,
        "duration": 3.73
    },
    {
        "text": "are trying to design antibodies to target\nand flush them out.",
        "start": 354.32,
        "duration": 2.849
    },
    {
        "text": "You might hear these drugs referred to as\nbiologics, because they’re biological molecules,",
        "start": 357.169,
        "duration": 4.021
    },
    {
        "text": "and they’re also being tested to treat other\ndiseases like cancer.",
        "start": 361.19,
        "duration": 3.08
    },
    {
        "text": "One antibody scientists are testing is aducanumab,\nwhich binds to small clumps of amyloid beta",
        "start": 364.27,
        "duration": 4.6
    },
    {
        "text": "before they’re deposited in plaques.",
        "start": 368.87,
        "duration": 2.069
    },
    {
        "text": "Right now, it’s in the last phase of clinical\ntrials before it could become publicly available.",
        "start": 370.939,
        "duration": 3.561
    },
    {
        "text": "A study from 2016 claimed that, according\nto brain scans, the antibody actually reduced",
        "start": 374.5,
        "duration": 5.969
    },
    {
        "text": "amyloid buildup in trial participants -- which\nwould be awesome if it works in these last tests.",
        "start": 380.469,
        "duration": 5.831
    },
    {
        "text": "Ongoing studies are expected to be published\nin 2019.",
        "start": 386.3,
        "duration": 2.13
    },
    {
        "text": "Unfortunately, a few biologics have already\ncrashed and burned, which is normal for clinical trials.",
        "start": 388.43,
        "duration": 5.57
    },
    {
        "text": "Not everything makes it through or works in\npeople like it does in a Petri dish.",
        "start": 394.009,
        "duration": 3.891
    },
    {
        "text": "So besides biologics, scientists are testing\na bunch of other strategies.",
        "start": 397.9,
        "duration": 3.31
    },
    {
        "text": "One is to block an enzyme that helps produce\namyloid beta fragments, called beta-secretase,",
        "start": 401.21,
        "duration": 4.579
    },
    {
        "text": "by using a so-called small molecule.",
        "start": 405.789,
        "duration": 2.311
    },
    {
        "text": "Most small molecule drugs are actually fairly\nbig -- they’re just tiny compared to things",
        "start": 408.1,
        "duration": 3.939
    },
    {
        "text": "like proteins.",
        "start": 412.039,
        "duration": 1.0
    },
    {
        "text": "Several of these are in early human trials,\nbut they’re not close to being ready for",
        "start": 413.039,
        "duration": 3.361
    },
    {
        "text": "the general public.",
        "start": 416.4,
        "duration": 1.0
    },
    {
        "text": "There are also drugs in development that go\nafter tau, rather than amyloid.",
        "start": 417.4,
        "duration": 3.68
    },
    {
        "text": "One is a vaccine called AADvac1.",
        "start": 421.08,
        "duration": 1.44
    },
    {
        "text": "A trial testing it with 185 people began in\n2015, and will end in February 2019.",
        "start": 422.52,
        "duration": 5.299
    },
    {
        "text": "A vaccine might be an odd-sounding idea, but\nit’s similar to the biologic approach.",
        "start": 427.819,
        "duration": 3.631
    },
    {
        "text": "With a biologic, you give the patient antibodies\nto attack a certain protein.",
        "start": 431.45,
        "duration": 4.54
    },
    {
        "text": "But with a vaccine, you stimulate their body\nto make its own antibodies, instead.",
        "start": 435.99,
        "duration": 4.099
    },
    {
        "text": "And it’s an interesting idea, but it’s\nnowhere near ready until these studies show",
        "start": 440.089,
        "duration": 3.45
    },
    {
        "text": "some results.",
        "start": 443.539,
        "duration": 1.19
    },
    {
        "text": "Besides just looking for cures, scientists\nare also researching ways to better diagnose",
        "start": 444.729,
        "duration": 3.84
    },
    {
        "text": "Alzheimer’s, since those plaques and tangles\ncan only be diagnosed for sure with an autopsy",
        "start": 448.569,
        "duration": 4.59
    },
    {
        "text": "-- although we can see the symptoms of the\ndisease long before then.",
        "start": 453.159,
        "duration": 3.1
    },
    {
        "text": "Finding biomarkers -- some kind of molecule\ndoctors can easily spot to confirm someone",
        "start": 456.259,
        "duration": 4.15
    },
    {
        "text": "has the disease -- is also a major goal.",
        "start": 460.409,
        "duration": 2.341
    },
    {
        "text": "That would help recruit reliable patients\nfor other studies, too.",
        "start": 462.75,
        "duration": 2.99
    },
    {
        "text": "But the thing about clinical trials is that,\nno matter how quickly we make discoveries,",
        "start": 465.74,
        "duration": 4.019
    },
    {
        "text": "it takes a long time to get them approved\nand completed.",
        "start": 469.759,
        "duration": 2.911
    },
    {
        "text": "Even if a medicine works in a lab, we want\nto be sure it will help.",
        "start": 472.67,
        "duration": 2.899
    },
    {
        "text": "And we definitely want to make sure it won’t\ndo more harm than good.",
        "start": 475.569,
        "duration": 3.19
    },
    {
        "text": "That takes a while, which is why you don’t\nhear about new treatments coming on the market",
        "start": 478.759,
        "duration": 3.58
    },
    {
        "text": "every week.",
        "start": 482.339,
        "duration": 1.0
    },
    {
        "text": "Also, even though scientists are doing a ton\nof research, they’ve still been struggling",
        "start": 483.339,
        "duration": 3.47
    },
    {
        "text": "to come up with anything that works really\nwell.",
        "start": 486.809,
        "duration": 2.181
    },
    {
        "text": "A lot of drugs have failed in clinical trials\n-- more than you’d normally expect -- and",
        "start": 488.99,
        "duration": 3.729
    },
    {
        "text": "there are a bunch of possible reasons why.",
        "start": 492.719,
        "duration": 1.831
    },
    {
        "text": "For one, drugs that affect the central nervous\nsystem are notoriously hard to develop because",
        "start": 494.55,
        "duration": 3.859
    },
    {
        "text": "brains are so complicated.",
        "start": 498.409,
        "duration": 1.84
    },
    {
        "text": "Also, treatments that looked promising in\nsmall trials often fail to scale up to larger ones.",
        "start": 500.249,
        "duration": 5.051
    },
    {
        "text": "And recruiting enough people for Alzheimer’s\ntrials has proven to be extremely difficult, too.",
        "start": 505.319,
        "duration": 4.581
    },
    {
        "text": "But the most troubling possible reason for\nall this failure is that researchers could",
        "start": 509.969,
        "duration": 3.331
    },
    {
        "text": "be barking up the wrong tree.",
        "start": 513.3,
        "duration": 1.56
    },
    {
        "text": "There’s good evidence to support the amyloid\nhypothesis, but all those failed drugs could",
        "start": 514.86,
        "duration": 3.94
    },
    {
        "text": "be evidence against it.",
        "start": 518.8,
        "duration": 1.179
    },
    {
        "text": "At least one major expert in the field has\nargued that Alzheimer’s is actually caused",
        "start": 519.979,
        "duration": 3.811
    },
    {
        "text": "by problems related to aging, not amyloid,\nincluding accumulation of DNA damage in the",
        "start": 523.79,
        "duration": 4.96
    },
    {
        "text": "brain, problems with the cell cycle, or loss\nof the fatty sheaths surrounding parts of neurons.",
        "start": 528.75,
        "duration": 5.45
    },
    {
        "text": "But we’ll need more evidence to be sure.",
        "start": 534.26,
        "duration": 1.63
    },
    {
        "text": "Most researchers aren’t ready to abandon\nthe amyloid hypothesis just yet, but it may",
        "start": 535.89,
        "duration": 4.11
    },
    {
        "text": "be worth considering down the road.",
        "start": 540.0,
        "duration": 1.42
    },
    {
        "text": "For now, we’ll just keep researching.",
        "start": 541.42,
        "duration": 2.09
    },
    {
        "text": "Because even if a trial or treatment doesn’t\nwork out, that’s still progress.",
        "start": 543.51,
        "duration": 3.15
    },
    {
        "text": "And in the meantime, doctors and caregivers\nare focusing on making sure patients’ lives",
        "start": 546.66,
        "duration": 3.78
    },
    {
        "text": "and their families are as comfortable as possible,\nwhether that means getting them the right",
        "start": 550.44,
        "duration": 3.6
    },
    {
        "text": "medicines or just the right daily routines.",
        "start": 554.04,
        "duration": 2.13
    },
    {
        "text": "Because at the end of the day, every person\nwith Alzheimer’s and dementia should get",
        "start": 556.17,
        "duration": 3.54
    },
    {
        "text": "the attention they need.",
        "start": 559.71,
        "duration": 1.13
    },
    {
        "text": "And hopefully, one day, we’ll find a cure\nfor both of them.",
        "start": 560.84,
        "duration": 2.84
    },
    {
        "text": "Thanks for watching this episode of SciShow.",
        "start": 563.68,
        "duration": 1.95
    },
    {
        "text": "For more on why we haven’t been able to\ncure major diseases, you can check out our",
        "start": 565.63,
        "duration": 3.53
    },
    {
        "text": "video on why we haven’t cured cancer.",
        "start": 569.16,
        "duration": 2.0
    },
    {
        "text": "[ ♪ Outro ♪ ]",
        "start": 571.16,
        "duration": 9.84
    }
]